x |
| Revenue for Orchid Cellmark Decreases by -5.55% even though Revenue for Biotech and Medical Products Industry Increases by 9.42% over Latest 12 Months |
|
Stock Quote: (NGM:ORCH) |
| 11/10/2009 |
|
| 1.60 |
 -0.07 |
-4.19% |
11,905 |
|
| Revenue for Orchid Cellmark Decreases by -5.55% even though Revenue for Biotech and Medical Products Industry Increases by 9.42% over Latest 12 Months |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, New York, November 10, 2009,T12-NEWS reports that Revenue for Orchid Cellmark (NASDAQ:ORCH) for its trailing twelve months (TTM) ended September 30, 2009 decreased by -5.55% to $56,298,000, ... read full story |
|
| Website Address: |
www.orchid.com |
| Industry: |
Bio Research Tools, Equip & Svcs
|
|
|
|
